MedTrace Logo

Aluminium Foil as an Adjuvant to Phototherapy for Pathological Unconjugated Hyperbilirubinaemia in Full Term Infants

NCT04433923 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-06-16

No results posted yet for this study

Summary

prospective single center pilot randomized open label clinical trial, conducted at the Neonatal care unit of Mansoura University Children's To assess the efficacy and safety of aluminum foil use in combination with phototherapy compared with phototherapy alone for pathological unconjugated hyperbilirubinaemia in full term newborn We enrolled 234 infants in the study who fulfilled the inclusion criteria and were randomly assigned to treatment groups, either conventional phototherapy with aluminum foil or conventional phototherapy alone.

Conditions

  • Neonatal Jaundice

Interventions

DEVICE

Phototherapy with aluminum foil

DEVICE

Phototherapy without aluminum foil

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Study Design

Purpose
TREATMENT

Eligibility

Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2018-12-01
Completion
2018-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04433923 on ClinicalTrials.gov